share_log

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga ·  Mar 22 17:33

Gainers

  • Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million.
  • Masimo (NASDAQ:MASI) shares rose 12.48% to $151.77. The company's market cap stands at $8.0 billion.
  • Vicarious Surgical (NYSE:RBOT) shares moved upwards by 11.17% to $0.38. The market value of their outstanding shares is at $66.7 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 11.11% to $2.2. The company's market cap stands at $8.0 million.
  • Psyence Biomedical (NASDAQ:PBM) stock increased by 9.09% to $1.2. The company's market cap stands at $16.0 million.
  • Bright Green (NASDAQ:BGXX) shares rose 8.02% to $0.29. The company's market cap stands at $53.2 million.

Losers

  • NextCure (NASDAQ:NXTC) shares declined by 9.5% to $1.72 during Friday's after-market session. The market value of their outstanding shares is at $47.9 million. As per the news, the Q4 earnings report came out yesterday.
  • Rockwell Medical (NASDAQ:RMTI) shares declined by 7.02% to $1.59. The market value of their outstanding shares is at $46.3 million. The company's, Q4 earnings came out yesterday.
  • Mesoblast (NASDAQ:MESO) shares fell 6.49% to $2.02. The company's market cap stands at $204.9 million.
  • Trevena (NASDAQ:TRVN) stock declined by 6.36% to $0.43. The market value of their outstanding shares is at $7.8 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares decreased by 6.03% to $0.42. The company's market cap stands at $6.7 million. As per the news, the Q4 earnings report came out yesterday.
  • Nutriband (NASDAQ:NTRB) stock fell 5.93% to $2.54. The market value of their outstanding shares is at $21.4 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment